doi:10.3969/j.issn.1673-8640.2025.11.012

Abstract

CLC Number:

R446.1

Figures/Tables 2

References 13

[1]	屈爱春, 郭平. 1例急性白血病患者多次血小板输注无效原因分析与解决思路[J]. 国际检验医学杂志, 2022, 43(3):381-384.
[2]	中国医师协会输血科医师分会, 中华医学会临床输血学分会. 血小板抗体检测专家共识[J]. 临床输血与检验, 2020, 22(1):1-5.
[3]	YANAGAWA B, RIBEIRO R, LEE J, et al. Platelet transfusion in cardiac surgery:a systematic review and meta-analysis[J]. Ann Thorac Surg, 2021, 111(2):607-614. DOI URL
[4]	中国输血协会人类组织抗原专业委员会, 中国输血协会免疫血液学专业委员会. 免疫性血小板输注无效的判定及临床实践专家共识[J]. 临床输血与检验, 2022, 24(3):273-278. DOI
[5]	BELIZAIRE R, MAKAR R S. Non-alloimmune mechanisms of thrombocytopenia and refractoriness to platelet transfusion[J]. Transfus Med Rev, 2020, 34(4):242-249. DOI PMID
[6]	韩瑜, 杨帆, 刘玲玲, 等. 吉林地区汉族人群血小板表面抗原基因多态性分析[J]. 中国实验诊断学, 2022, 26(1):100-103.
[7]	BUB C B, GONÇALEZ A C, BARJAS-CASTRO M L, et al. The use of a potential novel tool in virtual crossmatching for platelet transfusion in platelet refractoriness[J]. Vox Sang, 2016, 110(1):70-78. DOI PMID
[8]	韩冬梅, 汪沁, 唐宗生. 血小板抗体、血小板配型及输注次数对血液病患者的临床价值[J]. 皖南医学院学报, 2022, 41(2):153-156.
[9]	冯红梅, 蔡祥胜, 杨兆收, 等. 血小板抗体产生的影响因素分析[J]. 广东药科大学学报, 2019, 35(5):674-678.
[10]	SAREBAN N, MACHER S, DREXLER C, et al. Platelet antibody analysis by three different tests[J]. J Clin Lab Anal, 2015, 29(3):198-202. DOI PMID
[11]	江素君, 吕豪. 输血前检测血小板抗体的临床研究[J]. 临床血液学杂志(输血与检验版), 2015, 28(6):1053-1054.
[12]	梁雅珺, 王华, 赵沛喆, 等. 不同血小板配型方案在血小板输注无效患者中的输注效果分析[J]. 中华医学杂志, 2024, 104(11):865-869.
[13]	赵娜娜, 王超, 赵阳, 等. HLA单抗原特异性抗体检测技术治疗血小板输注无效的应用[J]. 安徽医学, 2023, 44(8):887-890.

组别	例数	血小板抗体阳性/ [例（%）]
血液病组	141	43（30.50）
肿瘤组	107	19（17.76）*
感染性疾病组	83	9（10.84）*
外伤和骨折组	76	9（11.84）*
肝胆消化疾病组	31	3（9.68）
心脑血管疾病组	41	2（4.88）
妇产科疾病组	49	4（8.16）
肾脏风湿疾病组	22	2（9.09）
其他疾病组	6	1（16.67）
χ²值		31.638
P值		<0.001

组别	例数	血小板抗体阳性/ [例（%）]
血液病组	141	43（30.50）
肿瘤组	107	19（17.76）*
感染性疾病组	83	9（10.84）*
外伤和骨折组	76	9（11.84）*
肝胆消化疾病组	31	3（9.68）
心脑血管疾病组	41	2（4.88）
妇产科疾病组	49	4（8.16）
肾脏风湿疾病组	22	2（9.09）
其他疾病组	6	1（16.67）
χ²值		31.638
P值		<0.001

输血次数	例数	阳性/[例（%）]	弱阳性/[例（%）]
0次	22	2（9.09）*	20（90.91）*
1次	18	4（22.22）*	14（77.78）*
2次	23	7（30.43）*	16（69.57）*
≥3次	29	13（44.83）	16（55.17）
χ²值		8.291
P值		0.040

输血次数	例数	阳性/[例（%）]	弱阳性/[例（%）]
0次	22	2（9.09）*	20（90.91）*
1次	18	4（22.22）*	14（77.78）*
2次	23	7（30.43）*	16（69.57）*
≥3次	29	13（44.83）	16（55.17）
χ²值		8.291
P值		0.040

[1]	BAO Wen. Application and prospect of microsatellite instability determination in tumor diagnosis and treatment [J]. Laboratory Medicine, 2025, 40(12): 1227-1231.
[2]	. [J]. Laboratory Medicine, 2025, 40(12): 1222-1226.
[3]	. [J]. Laboratory Medicine, 2025, 40(12): 1216-1221.
[4]	. [J]. Laboratory Medicine, 2025, 40(12): 1197-1202.
[5]	CHANG Nan, WEI Yali, LU Qifeng, LI Tian, HOU Tingting, LI Yuan, ZHU Mengyu, SHEN Yajuan. A machine learning early warning model for acute promyelocytic leukemia based on blood cell analyzer parameters [J]. Laboratory Medicine, 2025, 40(12): 1190-1196.
[6]	LI Song, XIANG Xu. Risk factors for poor prognosis in elderly patients with severe fever and thrombocytopenia syndrome and their clinical significance [J]. Laboratory Medicine, 2025, 40(12): 1183-1189.
[7]	ZHAO Yilin, XU Yan, YIN Hui. Roles of serum miR-145-5p，miR-200C-3p and miR-1290 in prognosis assessment of patients with papillary thyroid carcinoma [J]. Laboratory Medicine, 2025, 40(12): 1177-1182.
[8]	ZHEN Di, JIA Bin, MENG Xianyi. Roles of serum sPD-1 and sTWEAK levels in patients with ulcerative colitis in disease monitoring and prognosis assessment [J]. Laboratory Medicine, 2025, 40(12): 1171-1176.
[9]	LI Minghong, MIN Cuili, GUO Qingbo, MA Lujuan. Predictive roles of serum 25（OH）D and SAA for the response to immunosuppressive therapy in autoimmune hepatitis [J]. Laboratory Medicine, 2025, 40(12): 1165-1170.
[10]	HUANG Ting, XU Yan, SHI Qingxing, PENG Ying. Roles of miR-944 and MARCH7 mRNA in prognosis assessment of non-small cell lung cancer patients [J]. Laboratory Medicine, 2025, 40(12): 1159-1164.
[11]	WANG Tian, ZHANG Yun, BAI Yi, ZHAI Weibin, ZHAO Hai. Roles of PIV，SII and NPAR in the diagnosis of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites [J]. Laboratory Medicine, 2025, 40(12): 1153-1158.
[12]	GAO Zikang, CHEN Jing. Construction of a nomogram prediction model for the prognosis of patients with depressive disorder based on the characteristics of peripheral blood lymphocyte subsets [J]. Laboratory Medicine, 2025, 40(12): 1146-1152.
[13]	XIONG Ying, GUO Wei. From generic to personalized：the evolution and frontiers of indirect methods for establishing reference interval [J]. Laboratory Medicine, 2025, 40(11): 1035-1041.
[14]	CHEN Yanqin, FAN Lina, YANG Dagan. Six indirect method algorithms for establishing the reference range of serum cystatin C for adults in Hangzhou and consistency analysis [J]. Laboratory Medicine, 2025, 40(11): 1047-1052.
[15]	LIU Chunyan, NIU Shumin, DENG Zhaohui, LIANG Mengjie, ZHANG Xin. Establishing the reference ranges for AFP，CEA，CA72-4 and CA19-9 in Urumqi region by indirect method [J]. Laboratory Medicine, 2025, 40(11): 1053-1058.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 13

Related Articles 15

Recommended Articles

Metrics